Skip to content
Monday, November 16, 2026
Modern Cards Space

Individuals Discontinuing Weight-Loss Jabs Gain Back Weight Far More Rapidly Compared to Dieters

Illustration of pharmaceutical syringe and weighing machine
Weight management often requires ongoing approaches.

New research indicates that individuals who stop using new slimming jabs like Wegovy and Mounjaro can put back on reduced body mass much more quickly than those who halt traditional lifestyle programs.

Published data in a prominent medical journal demonstrates that while obese individuals frequently drop a large proportion of their total mass while on the medication, the mass is regained at an estimated rate of 0.8 kg per month once they quit.

"Individuals purchasing these treatments should be aware of the potential of quick rebound weight gain when the treatment ends," warns expert Dr. Susan Jebb.

That rate of recovery means a return to starting mass in about 18 months.

Comparing Therapies

The research, which examined 37 of studies involving over 9,000 of participants, contrasted the results of GLP-1 agonists with conventional dieting.

Scientists note that individuals who shed pounds through dieting usually see a slower weight regain—perhaps 0.1 kg a month—after stopping.

The Reason for the Rapid Regain

Doctors suggest the mode of action of the drugs explains the accelerated regain.

These medications mimic a body's own chemical called GLP-1, which moderates feelings of fullness.

"Artificially providing GLP-1 levels far above than normal may cause the system to produce less of its own natural GLP-1, and could reduce sensitivity to its actions," said Dr. Adam Collins, a dietetics researcher.

"Discontinuation of this medication results in hunger is unsuppressed, making overeating far more likely."

An Ongoing Disease?

Health authorities suggest the injections for people with weight-linked health risks, accompanied by recommended lifestyle changes.

Many experts argue that, due to the likelihood of weight regain, the therapy might need to be ongoing.

This view is supported by pharmaceutical companies, who say that the findings "highlight the long-term nature of obesity," similar to managing conditions like hypertension.

User Experiences

Individuals who have stopped the jabs explain a intense return of cravings.

"I experienced a switch that goes on and I was suddenly extremely hungry," described an individual.

This challenge is compounded if individuals have not developed lasting lifestyle or habit modifications during treatment.

Growing Interest

Recent estimates indicate that millions of people in the UK have used these injections in the past year, with demand remaining high.

  • Use is more common among women than males.
  • The 40s and 50s age group shows the highest usage rates.
  • Many obtain the drugs through private prescriptions rather than the NHS.

In conclusion, experts emphasize that while GLP-1 drugs are powerful tools for weight loss, they are not a magic cure and lasting health benefits hinges on integrated behavioural management.

SH
About the author

Sharon Howard

A graphic designer and card-making enthusiast with over a decade of experience in creative arts and digital design.

Modern Cards Space

Type to search articles.